TAZAROTENE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
45802-706 -
Package NDC
45802-706-94 -
Package NDC
45802-706-96 -
Application number
ANDA217075 -
SPL ID
27ddf7ba-f3a2-43ff-83a5-e7c95b355028 -
SPL set ID
df5d65de-0693-4fd2-b335-f04ab1e201e7 -
UNII
81BDR9Y8PS -
RxCUI
314268
What the source publishes
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Active ingredients
- tazarotene
- Form
- CREAM
- Routes
- TOPICAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "TAZAROTENE",
"splId": "27ddf7ba-f3a2-43ff-83a5-e7c95b355028",
"labels": [
{
"setId": "df5d65de-0693-4fd2-b335-f04ab1e201e7",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=df5d65de-0693-4fd2-b335-f04ab1e201e7",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=df5d65de-0693-4fd2-b335-f04ab1e201e7"
}
],
"routes": [
"TOPICAL"
],
"labeler": "Padagis Israel Pharmaceuticals Ltd",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 TUBE in 1 CARTON (45802-706-94) / 30 g in 1 TUBE",
"package_ndc": "45802-706-94",
"identifierStatus": "well-formed",
"marketing_start_date": "20240909"
},
{
"sample": false,
"description": "1 TUBE in 1 CARTON (45802-706-96) / 60 g in 1 TUBE",
"package_ndc": "45802-706-96",
"identifierStatus": "well-formed",
"marketing_start_date": "20240909"
}
],
"productId": "45802-706_27ddf7ba-f3a2-43ff-83a5-e7c95b355028",
"useDomain": "unknown",
"dosageForm": "CREAM",
"productNdc": "45802-706",
"deaSchedule": null,
"genericName": "tazarotene",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "TAZAROTENE",
"strength": ".5 mg/g"
}
],
"applicationNumber": "ANDA217075",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20240909",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175607",
"M0018962"
],
"unii": [
"81BDR9Y8PS"
],
"rxcui": [
"314268"
],
"spl_set_id": [
"df5d65de-0693-4fd2-b335-f04ab1e201e7"
],
"pharm_class_cs": [
"Retinoids [CS]"
],
"pharm_class_epc": [
"Retinoid [EPC]"
],
"manufacturer_name": [
"Padagis Israel Pharmaceuticals Ltd"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:45802-706_27ddf7ba-f3a2-43ff-83a5-e7c95b355028"